Aromatherapy Massage for Itching Management in Liver Diseases
The Effect of Aromatherapy Massage on Itching, Comfort, Skin pH Level, and Skin Moisture in Liver Diseases: Randomised Controlled Trial
1 other identifier
interventional
36
1 country
1
Brief Summary
The aim of this study is to determine the effect of aromatherapy massage on itching, comfort, skin pH level and skin moisture in individuals with liver disease. Research Hypotheses: H1: Aromatherapy massage has an effect on the level of itching in individuals with itchy liver disease. H2: Aromatherapy massage has an effect on the general comfort level in individuals with itchy liver disease, H3: Aromatherapy massage has an effect on skin pH level in individuals with itchy liver disease. H4: Aromatherapy massage has an effect on skin moisture in individuals with itchy liver disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 23, 2021
CompletedFirst Submitted
Initial submission to the registry
April 18, 2022
CompletedFirst Posted
Study publicly available on registry
May 10, 2022
CompletedJanuary 29, 2025
May 1, 2022
1.2 years
April 18, 2022
January 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Itching
Itching was assessed with the 5D Itch Scale. The total score of the scale ranges from 5 to 25, with 5 points indicating the absence of itching and 25 points indicating the highest severity of itching.
Day 1
Itching
Itching was assessed with the 5D Itch Scale. The total score of the scale ranges from 5 to 25, with 5 points indicating the absence of itching and 25 points indicating the highest severity of itching.
Day 14
comfort
Comfort assessed with the General Comfort Scale. The score to be obtained from the scale varies between 48 and 192. 48 points indicating the low comfort level and 192 points indicating the high comfort level.
Day 1
comfort
Comfort assessed with the General Comfort Scale.The score to be obtained from the scale varies between 48 and 192. 48 points indicating the low comfort level and 192 points indicating the high comfort level.
Day 2
comfort
Comfort assessed with the General Comfort Scale. The score to be obtained from the scale varies between 48 and 192. 48 points indicating the low comfort level and 192 points indicating the high comfort level.
Day 14
skin pH level
For pH level measurement, the F-74 G model skin pH measuring device manufactured by HORIBA Scientific and ISFET (Ion Sensitive Field Effect Transistor) 0040-10D model pH electrode produced by HORIBA Scientific were used.
Day 1
skin pH level
For pH level measurement, the F-74 G model skin pH measuring device manufactured by HORIBA Scientific and ISFET (Ion Sensitive Field Effect Transistor) 0040-10D model pH electrode produced by HORIBA Scientific were used.
Day 2
skin pH level
For pH level measurement, the F-74 G model skin pH measuring device manufactured by HORIBA Scientific and ISFET (Ion Sensitive Field Effect Transistor) 0040-10D model pH electrode produced by HORIBA Scientific were used.
Day 14
skin moisture level
DMM brand skin moisture measuring device was used to measure skin moisture level.
Day 1
skin moisture level
DMM brand skin moisture measuring device was used to measure skin moisture level.
Day 2
skin moisture level
DMM brand skin moisture measuring device was used to measure skin moisture level.
Day 14
Study Arms (3)
aromatherapy
EXPERIMENTALIn addition to routine medical treatment, massage with diluted tea tree oil was applied to the individuals in this group.
placebo
PLACEBO COMPARATORIndividuals in this group were provided massage with sweet almond oil in addition to routine medical treatment.
control
NO INTERVENTIONIndividuals in this group received only routine medical treatment.
Interventions
massage with diluted tea tree oil was applied
Eligibility Criteria
You may qualify if:
- patients who volunteered to participate in the study,
- with a diagnosis of chronic liver disease (liver cirrhosis (primary biliary cirrhosis, alcoholic, cardiac, post-necrotic, cryptogenic cirrhosis, Wilson's Cirrhosis, hemochromatosis), chronic viral hepatitis),
- had no cognitive impairment,
- were not included in the pre-application,
- could answer questions,
- itch score of above 3 (with Visual Analogue Scale).
You may not qualify if:
- patients are taking antipruritic treatment,
- have itchy skin disease before, ulcer, eczema, etc. in the area to be applied
- patients with dermatological problems, any swelling or signs of inflammation in the area ---to be treated, neuropathy or loss of sensation in the area to be treated
- patients with allergic to tea tree oil, perfume, or cosmetics,
- diagnosed with cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amine Terzilead
Study Sites (1)
Artvin Coruh University
Artvin, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amine TERZI, PHD
Artvin Coruh University
- STUDY DIRECTOR
Yasemin YILDIRIM, PHD
Ege University
- STUDY CHAIR
Fisun SENUZUN AYKAR, PHD
Izmir Tinaztepe University
- STUDY CHAIR
Ulus Salih AKARCA, PHD
Ege University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Asst. Prof.
Study Record Dates
First Submitted
April 18, 2022
First Posted
May 10, 2022
Study Start
February 13, 2020
Primary Completion
May 3, 2021
Study Completion
June 23, 2021
Last Updated
January 29, 2025
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share